A Multidisciplinary Teaching Team
The MSc (ELBT) programme is taught by a multidisciplinary team comprising HKUST faculty and experienced industry practitioners from across the biotechnology innovation ecosystem. The team includes academic experts alongside founders, senior executives, and professionals from biotech and pharmaceutical companies, CROs, IP and regulatory advisory firms, and investment and innovation platforms.
With extensive hands-on experience in technology commercialization, regulatory strategy, and business execution, the teaching team ensures students gain both solid conceptual foundations and practical insights required to lead and scale biotechnology ventures in Hong Kong, Mainland China, and global markets.
Faculty Members from the Division of Life Science
PhD Cambridge
Chair Professor
Program Director
Nutraceutical Development and Registration; Herbal Medicine Product Development; Director of Center for Chinese Medicine Research and Development.
View Profile
PhD University of Manchester Institute of Science and Technology
Associate Program Director
View Profile
Honorary Fellow of the Hong Kong University of Science and Technology
Adjunct Professor
President of HK Bio-Med Innotech Association; Strategic Advisor to The President, Hong Kong University of Science and Technology
PhD University of Connecticut Health Center
Adjunct Professor
President of Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.; Chief Scientific Officer of Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd.
PhD Weizmann Institute of Science;
MD Southeast University Medical School
Adjunct Professor
Co-Founder of Drug Development and Filing Consulting; Venture Partner, Shanghai Healthcare Capital; Member, Society of Physician Entrepreneurs; ex-Medical Officer / Program Officer at the US NIH
JD Suffolk University Law School
Adjunct Professor
President and Managing Director, Eagle IP; Chair, IP Practice in China Committee, AIPLA (American Intellectual Property Law Association); US (Massachusetts) bar qualified; Registered US patent attorney (USPTO); Founder of China Patent Strategy (IP law blog).
PhD The Hong Kong Polytechnic University;
Honorary Fellow of the Hong Kong University of Science and Technology
Adjunct Professor
Chairman, Group Sense Limited; President of Hong Kong Industry-University-Research Collaboration Association; Founding Partner of Hong Kong INNO Angel Fund; Board Member of Hong Kong Science and Technology Parks Corporation.
PhD Browm University
Adjunct Associate Professor
General Partner, Dianliang Capitals; Board member of three listed technology companies (current and past); VC/PE consultant for multiple information technology enterprises;
Former duties include: Chairman of the Qianhai (前海）International Blockchain Alliance; Council Member of the Hong Kong Industry-University-Research Collaboration Promotion Association; Director of the Young Entrepreneurs Development Council.
PhD Sung Kyun Kwan University
Adjunct Associate Professor
Managing Director, Jedus Bio limited; Biotech & Medtech business consultant; former APAC business leader at Fresenius Medical Care and global marketing leader at Johnson & Johnson, with 30 years of leadership experience across global healthcare companies including Eli Lilly and Baxter, specialising in APAC commercialisation, market access and business development.
PhD University of Toronto
Adjunct Assistant Professor
Associate Editor, Therapeutic Innovation & Regulatory Science; Vice President, Hong Kong Exchanges and Clearing Limited; Chairman, Biomedical Impact Association
The MSc in ELBT programme is further enriched by a distinguished panel of guest lecturers drawn from senior commercial leadership across the pharmaceutical, biotech, medtech, legal, IP, and healthcare-investment sectors. These industry leaders bring first-hand experience in global commercial operations, corporate strategy, intellectual property, and healthcare investment to complement the programme's academic curriculum.
Guest Lecturers from Senior Commercial Leaders
MPhil (Management), Columbia Business School; CPA (US); CFA
Founder & Managing Partner, GT Healthcare
Founder of GT Healthcare Capital, a private-equity fund focused on cross-border life science investments (since 2015); Board Member, NovaBridge Biosciences (Nasdaq: NBP); Board Member & Audit Committee Chair, CSPC Pharmaceutical Group (HKEX: 1093); Independent Director, TJ Biopharma Group Hangzhou; Co-founder, Apeiron Therapeutics Inc.; Co-founder, PrimaNova Technologies Inc.; Board Member, Moon Surgical Paris; former Head of Asia Healthcare Investment Banking, Deutsche Bank; former Investment Director, JAFCO Asia and Morningside Group; former panel member, Innovation and Technology Fund, HKSAR Government.
JD, Columbia University School of Law; PhD (Virology), Baylor College of Medicine
Partner, Kinect Law, PLLC (US) / Consultant, Long An & Lam LLP (Hong Kong)
Registered US Patent Attorney (USPTO, since 1993); admitted to practice in New Jersey, New York, Texas, Massachusetts and before the US Supreme Court; admitted to the High Court of Hong Kong (2023); Adjunct Associate Professor, CUHK School of Life Sciences and PolyU Department of Health Technology & Informatics; former Adjunct Professor, City University of New York School of Law (1996–2013); Founder & Director, US–China Intellectual Property Institute; postdoctoral fellow (American Cancer Society), Cold Spring Harbor Laboratory.
PhD (HKUST); MBA (University of Toronto & Shanghai Jiatong University)
Former Head of Biotechnology and Entrepreneurship Support, Office of Knowledge Transfer, HKUST
Experience in IP commercialization, industry partnerships, licensing, startups, and investment. Over 25 years of experience in identifying and commercialising university technologies, managing strategic IP portfolios, developing industry partnerships, securing proof-of-concept and gap funding, and guiding research teams from early-stage validation to licensing, start-up formation and investment. His expertise covers most of areas in biotechnology such as therapeutics, biosensors, bioelectronics and biomedical technologies, etc.
MRPharmS (Member, Royal Pharmaceutical Society, UK)
Former Country Manager, Pfizer Hong Kong & Indonesia
38-year international pharmaceutical career across the UK, Australia, New York and Asia Pacific (retired from Pfizer in 2022); led Pfizer HK to the HKMA Quality Gold Award, Outstanding Corporate Citizenship Gold Award and Best Companies to Work for in Asia; Former Chairman, CUHK School of Pharmacy Advisory Board; Non-Executive Director, PuraPharm; Council Member, Hong Kong Management Association; Fellow, HK College of Health Service Executives (FHKCHSE), FCHSM, FCPP; certified Corporate Coach (ICF PCC); recipient of the Asia Coaching Leadership Excellence Award (2015), Leader of the Year Award (2016) and Exemplary Leader Award (Global HR Excellence, 2021).
BSc, FMBA, D.Mgt, FHKIoD, FHKIE, SMIEEE
Co-founder and Chairman of AML Holdings Ltd
Over 40 years in Design & Manufacturing of Electronic and BioMedical products. He led AML Group in winning several Industry Awards. He serves society as Directorship & Entrepreneurship Coach, Angel Investor and Philanthropist. He also has been: Founding Chairman of HK MedTech Association; Fellow, Awardee, & SME Committee Chairman of HKIoD; Fellow & Past Chairman BME Division of HKIE; Adjunct Professor and Advisory Committee Chairman at several university in HK and China.
PhD (Chemistry) & MPhil (Pharmacology), University of Cambridge
General Manager, Roche Diagnostics Korea
Kit architects ecosystems that bridge the gap between innovation and societal impact, and transform complexity into scalable commercial execution. His professional journey has been a transition from publishing research on drug-target interaction and protein folding, running startups, to leading people and operations in various markets covering clinical laboratory automation, digital health and next-generation sequencing.
MSc in Computer, Science University of York,
Doctor of Management Candidate, the Hong Kong Polytechnic University
Founder & Chief Executive Officer, Genn Capital Ltd.
Chairman, Cookies Quartet Ltd.
Wang Xiaoming is the founder of the Twin-Wheel Growth (增長雙輪) and Simple Agile (輕敏捷) management methodologies and the author of three best-selling management books: Twin-Wheel Growth (《增長雙輪》), The Tencent Way (《騰訊方法》), and Transformation (《轉型》). Prior to his current roles, he served as a Senior Management Consultant at Tencent (00700) and President of Xunlei Group (XNET).
M.Phil (Molecular Microbiology) & B.Sc. (Animal & Plant Biotechnology), The University of Hong Kong
Principal, Eagle IP
Chinese Patent Attorney with over 11 years' experience; leads the firm's patent drafting team and manages local and global patent prosecution portfolios; extensive experience drafting and prosecuting patents in biotechnology, medical devices, chemistry, engineering, materials science and mechanical technologies; brings prior R&D and industry experience from CK Life Sciences; passionate about mentoring patent professionals and sharing practical intellectual property insights through seminars, workshops and guest lectures at universities, research institutions and entrepreneurship programmes.